Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Basic) (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of EPS (Basic) data on record, last reported at $0.14 in Q3 2025.

  • For Q3 2025, EPS (Basic) rose 118.42% year-over-year to $0.14; the TTM value through Jun 2025 reached -$0.9, up 70.97%, while the annual FY2024 figure was -$2.69, 68.24% up from the prior year.
  • EPS (Basic) reached $0.14 in Q3 2025 per FBIO's latest filing, down from $0.5 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.5 in Q2 2025 and bottomed at -$15.29 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$1.49, with a median of -$0.38 recorded in 2021.
  • Peak YoY movement for EPS (Basic): crashed 3923.68% in 2022, then surged 168.49% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.38 in 2021, then tumbled by 3923.68% to -$15.29 in 2022, then skyrocketed by 96.53% to -$0.53 in 2023, then surged by 69.81% to -$0.16 in 2024, then surged by 187.5% to $0.14 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $0.14 in Q3 2025, $0.5 in Q2 2025, and -$0.48 in Q1 2025.